| 4 | Rubric Capital Management LP | 10.2M | $176.0M | -7.9% | 3.184% | 1.61% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 7.7M | $133.5M | +1.7% | 2.414% | 0.00% |
| 6 | STATE STREET CORP | 7.4M | $127.3M | +8.3% | 2.304% | 0.00% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 5.8M | $100.3M | +1.8% | 1.815% | 0.02% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 5.1M | $89.0M | +13.1% | 1.609% | 0.00% |
| 9 | MORGAN STANLEY | 4.1M | $71.1M | -11.4% | 1.287% | 0.00% |
| 10 | Neuberger Berman Group LLC | 3.9M | $67.3M | +5.6% | 1.217% | 0.02% |
| 11 | Invesco Ltd. | 3.5M | $60.6M | +9.8% | 1.097% | 0.00% |
| 12 | Nuveen, LLC | 3.3M | $57.6M | +2.5% | 1.041% | 0.01% |
| 13 | Allspring Global Investments Holdings, LLC | 3.3M | $55.9M | +29.3% | 1.032% | 0.09% |
| 14 | GOLDMAN SACHS GROUP INC | 3.0M | $52.2M | +5.2% | 0.944% | 0.00% |
| 15 | Assenagon Asset Management S.A. | 2.4M | $42.3M | -20.3% | 0.766% | 0.03% |
| 16 | Nantahala Capital Management, LLC | 2.3M | $39.3M | -20.2% | 0.711% | 0.65% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1M | $37.2M | -1.7% | 0.672% | 0.00% |
| 18 | NORTHERN TRUST CORP | 1.9M | $33.1M | +12.2% | 0.600% | 0.00% |
| 19 | AMERIPRISE FINANCIAL INC | 1.6M | $27.4M | -15.2% | 0.495% | 0.01% |
| 20 | Westshore Wealth, LLC | 1.4M | $23.7M | -0.6% | 0.428% | 7.34% |
| 21 | BlackBarn Capital Partners LP | 1.3M | $22.5M | -21.2% | 0.407% | 1.90% |
| 22 | Penn Capital Management Company, LLC | 1.2M | $20.5M | -1.3% | 0.370% | 1.30% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $20.2M | +1.3% | 0.366% | 0.00% |
| 24 | CITADEL ADVISORS LLC | 1.1M | $19.9M | +85.3% | 0.359% | 0.00% |
| 25 | Bank of New York Mellon Corp | 1.0M | $17.6M | +11.1% | 0.318% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in AMRX — a direct measure of their conviction.
| 39.80% |
| +3.89 pp |
| $1.04B |
| +18% |
| Q4 2024 | 197 | +8.8% | 35.91% | 5.65 pp | $880M | 18% |
| Q3 2024 | 181 | — | 41.56% | — | $1.07B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
41 institutions opened new positions in AMRX during Q2 2026, while 50 fully exited. 238 added to existing positions and 21 trimmed.
AMRX institutional ownership rose by 1.09 percentage points quarter-over-quarter, with a net change of -5 holders.
The top 10 institutions account for 59.7% of all reported 13F value in AMRX, and the top 25 account for 78.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Amneal Pharmaceuticals, Inc. (AMRX) Institutional Ownership